Old Web
English
Sign In
Acemap
>
authorDetail
>
Greg Dueck
Greg Dueck
University of British Columbia
Pathology
Medicine
Internal medicine
Lymphoma
Obinutuzumab
2
Papers
92
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study
2018
Journal of Clinical Oncology
Bruce D. Cheson
Neil Chua
Jiri Mayer
Greg Dueck
Marek Trneny
Kamal Bouabdallah
Nathan Fowler
Vincent Delwail
Oliver W. Press
Gilles Salles
John G. Gribben
Anne Lennard
Pieternella J. Lugtenburg
Günter Fingerle-Rowson
F. Mattiello
Andrea Knapp
Laurie H. Sehn
Show All
Source
Cite
Save
Citations (65)
Activity of lenalidomide in a phase II trial for T-cell lymphoma: Report on the first 24 cases
2009
Journal of Clinical Oncology
Greg Dueck
Neil Chua
Angeli Prasad
D. Stewart
D. White
R. vanderJagt
James B. Johnston
Andrew R. Belch
T. Reiman
Show All
Source
Cite
Save
Citations (27)
1